Pharmacists in Glendora, CA Accepting Medicare

46 Pharmacists found. Showing 1 - 20

Michelle Wendy Lam, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 S Grand Ave Ste 116, Glendora, CA 91741 Phone: 626-335-2300

Diane Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 435 E Arrow Hwy, Glendora, CA 91740 Phone: 626-963-1625    Fax: 626-852-9919

Poh San Tan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 W Route 66, Glendora, CA 91740 Phone: 626-963-5325    Fax: 626-963-5346

Rita Sawabini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1950 Auto Centre Dr, Glendora, CA 91740 Phone: 909-593-6268    Fax: 909-599-5401

Eric Sirich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 707 W Route 66, Suite 103, Glendora, CA 91740 Phone: 626-335-0011    Fax: 626-335-1499

Dr. Mai Phuong Thai, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1844 E Route 66, Glendora, CA 91740 Phone: 626-335-4777    Fax: 626-335-4774

Dr. Yolanda Yanez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 435 W Foothill Blvd, Glendora, CA 91741 Phone: 626-963-3281    Fax: 626-963-5213

John S Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 159 N Glendora Ave, Glendora, CA 91741 Phone: 626-335-0221    Fax: 626-335-2913

Teresa Tan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 N Grand Ave, Glendora, CA 91741 Phone: 626-963-0385

Steffanie Sang Mouy Ung Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 130 N Grand Ave, Glendora, CA 91741 Phone: 626-963-0385

Aya Zeyad Alwahib, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 N Grand Ave, Glendora, CA 91741 Phone: 626-963-0385

Chihuong Luong, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 S Grand Ave, Glendora, CA 91741 Phone: 626-857-0633    Fax: 626-857-0894

Dr. Duy-anh Dang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 S Grand Ave Ste 116, Glendora, CA 91741 Phone: 626-335-2300

Dr. Derrick Thanh Pham, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 S Grand Ave, Glendora, CA 91741 Phone: 626-857-0633

Sherine Tadros Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 W Route 66, Glendora, CA 91740 Phone: 626-963-5325    Fax: 626-963-5346

Kaye Pantayatiwong Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 N Grand Ave, Glendora, CA 91741 Phone: 626-963-0385

John William Kyle Iii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 727 E Meda Ave, Glendora, CA 91741 Phone: 626-340-9669

Li-yu Ku, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 130 N Grand Ave, Glendora, CA 91741 Phone: 626-963-0385

Miss Cheryl Ann Ensign Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 S Grand Ave, Glendora, CA 91740 Phone: 626-857-9439

Caroline Riad Antoun Riad, REGISTERED PHARMACIS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1473 Lawford St, Glendora, CA 91741 Phone: 626-756-2528

News Archive

Immunization against flu during pregnancy can influence fetal growth

Vaccinating pregnant women against the influenza virus appears to have a significant positive effect on birth weight in babies, according to a study published in CMAJ.

Weight gain and other metabolic side effects of bipolar and schizophrenia drugs may be countered

A new study suggests that young people who are diagnosed with bipolar disorder and schizophrenia may be spared the side-effects of taking medication with the right diet and exercise program.

Soligenix reports positive results from SGX942 Phase 2 trial in patients with head and neck cancer

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today positive results in its Phase 2 clinical trial, in which SGX942, a first-in-class Innate Defense Regulator (IDR), at a dose of 1.5 mg/kg, successfully reduced the median duration of severe oral mucositis by 50% in all patients and by 67% in patients receiving the most aggressive chemoradiation therapy (CRT) for treatment of their head and neck cancer.

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.

Read more Medical News

› Verified 3 days ago

• 1(current)
• 2
• 3